Osaic Holdings
AGIO icon

Osaic Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Osaic Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.1K Sell
1,592
-194
-11% -$5.88K ﹤0.01% 5356
2026
Q1 		$60.4K Buy
1,786
+39
+2% +$1.11K ﹤0.01% 5062
2025
Q4 		$47.6K Buy
1,747
+1,411
+420% +$49.5K ﹤0.01% 5267
2025
Q3 		$13.5K Sell
336
-11
-3% -$414 ﹤0.01% 6183
2025
Q2 		$11.5K Buy
347
+312
+891% +$9.46K ﹤0.01% 6060
2025
Q1 		$1.03K Sell
35
-245
-88% -$8.13K ﹤0.01% 6806
2024
Q4 		$9.2K Sell
280
-75
-21% -$3.52K ﹤0.01% 5853
2024
Q3 		$15.8K Sell
355
-9
-2% -$409 ﹤0.01% 5518
2024
Q2 		$15.7K Sell
364
-18
-5% -$650 ﹤0.01% 5510
2024
Q1 		$11.2K Buy
382
+279
+271% +$7.47K ﹤0.01% 5694
2023
Q4 		$2.29K Hold
103
– – ﹤0.01% 6495
2023
Q3 		$2.55K Buy
103
+26
+34% +$688 ﹤0.01% 6539
2023
Q2 		$2.18K Hold
77
– – ﹤0.01% 6635
2023
Q1 		$1.77K Sell
77
-250
-76% -$6.64K ﹤0.01% 6769
2022
Q4 		$9.26K Buy
327
+41
+14% +$1.16K ﹤0.01% 5974
2022
Q3 		$8K Buy
286
+162
+131% +$4.34K ﹤0.01% 6100
2022
Q2 		$3K Sell
124
-344
-74% -$7.77K ﹤0.01% 6687
2022
Q1 		$14K Sell
468
-117
-20% -$3.58K ﹤0.01% 5919
2021
Q4 		$20K Sell
585
-261
-31% -$10.5K ﹤0.01% 5779
2021
Q3 		$39K Sell
846
-679
-45% -$32.8K ﹤0.01% 5288
2021
Q2 		$84K Buy
1,525
+182
+14% +$10.2K ﹤0.01% 4632
2021
Q1 		$70K Sell
1,343
-58
-4% -$2.87K ﹤0.01% 4629
2020
Q4 		$59K Buy
1,401
+218
+18% +$8.62K ﹤0.01% 4442
2020
Q3 		$42K Sell
1,183
-84
-7% -$3.68K ﹤0.01% 4428
2020
Q2 		$68K Buy
1,267
+1,027
+428% +$47.6K ﹤0.01% 3964
2020
Q1 		$9K Buy
+240
New +$11.1K ﹤0.01% 5045

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Osaic Holdings's AGIO Position: Q2 2026 in Review

Osaic Holdings reduced its Agios Pharmaceuticals (AGIO) stake by 11% in Q2 2026, selling an estimated $5.88K and leaving 1,592 shares worth $59.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5356.

Osaic Holdings first reported a position in AGIO in Q1 2020 and has held it in 26 quarters since. The position peaked at $84K in Q2 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Osaic Holdings held 1,592 shares of Agios Pharmaceuticals worth $59.1K as of Q2 2026.
  • Osaic Holdings sold 194 Agios Pharmaceuticals shares in Q2 2026, an estimated $5.88K.
  • Agios Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5356 holding.
  • Osaic Holdings first reported a position in Agios Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Agios Pharmaceuticals position peaked at $84K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.